echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > New strategy for nasal tuberculosis vaccine development, more potential for cancer treatment

    New strategy for nasal tuberculosis vaccine development, more potential for cancer treatment

    • Last Update: 2021-09-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Mycobacterium tuberculosis (Mtb) is the leading cause of death worldwide, causing more than 1.


    Researchers at Purdue University and Houston Methodist University combined autophagy-mediated antigen presentation to create this new tuberculosis vaccine formulation, which initiates an enhanced T cell response


    Mittal said: "Our vaccination method is equally effective without or with prior BCG vaccination


    Jagannath said: "This is crucial because most people in countries where tuberculosis is endemic have already been vaccinated with BCG


    Mittal's laboratory researches vaccine delivery platforms, and Jagannath's laboratory uses the nasal delivery route in the development of tuberculosis vaccines


    Mittal said: "The great thing about this TB research is that it can be transformed into other infectious diseases, and possibly cancer immunotherapy


    The next step in the vaccine formulation is to study the efficacy of the vaccine in a non-human primate model



    Arshad Khan, Ekramy E.




    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.